Effect of Sitagliptin in Impaired Glucose Tolerance
NCT00961363
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Impaired Glucose Tolerance
Interventions
DRUG:
Sitagliptin
DRUG:
Placebo
Sponsor
National Taiwan University Hospital